Intra-Cellular Therapies Inc

NASDAQ:ITCI   3:59:54 PM EDT
38.63
+0.09 (+0.23%)
Earnings Announcements

Intra-Cellular Therapies Reports Third Quarter 2021 Financial Results

Published: 11/09/2021 12:41 GMT
Intra-Cellular Therapies Inc (ITCI) - Intra-cellular Therapies Reports Third Quarter 2021 Financial Results and Provides Corporate Update.
Q3 Revenue Rose 200 Percent to $22.2 Million.
Qtrly Loss per Share $0.95.
Q3 Earnings per Share View $-0.92 -- Refinitiv Ibes Data (analyst estimates).
Q3 Revenue View $22.1 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $25.59 Million
Adjusted EPS is expected to be -$1.00

Next Quarter Revenue Guidance is expected to be $34.97 Million
Next Quarter EPS Guidance is expected to be -$0.89

More details on our Analysts Page.